Table 2.
Functions of methyl-CpG binding proteins
MBP | Major activity | Species | Major phenotypes of loss-of-function mutations |
---|---|---|---|
MeCP2 | Binds mCpG with adjacent run AT-rich run Transcriptional repressor | Mouse | Delayed onset neurological defects including inertia, hindlimb clasping, nonrhythmic breathing, and abnormal gait. Postnatal survival ∼10 wk. |
MECP2 | Binds mCpG with adjacent AT run Transcriptional repressor | Human | Heterozygotes suffer from Rett syndrome, a profound neurological disorder characterized by apraxia, loss of purposeful hand use, breathing irregularities, and microcephaly |
Mbd1 | Binds mCpG via MBD; a major splice form is also able to bind CpG via a CxxC domain | Mouse | No overt phenotype, but subtle defects in neurogenesis detected |
Mbd2 | Binds mCpG Transcriptional repressor | Mouse | Viable and fertile, but show reduced maternal nurturing behavior. Defective gene regulation in T-helper cell differentiation leading to altered response to infection. Highly resistant to intestinal tumorigenesis. |
Mbd3 | Core component of NuRD corepressor complex Does not show strong binding to mCpG | Mouse | Early embryonic lethal |
Mbd4 | DNA repair protein that binds mCpG and T:G mismatches at mCpG sitesThymine DNA glycosylase that excises T from T:G mismatches | Mouse | Viable and fertile. three- to fourfold increase in mutations at CpG sites. Increased susceptibility to intestinal cancer correlates with C to T transitions within the Apc gene. Mbd4 functions to minimize the mutability of 5-methylcytosine. |
Kaiso | Binds mCGmCG and CTGCNA Transcriptional repressor | Mouse | No overt phenotype. Small but significant delay in tumorigenesis on Min background. |